UBS Boosts Conviction in Singapore Equities’ Bull Market Run
(Bloomberg) -- The Singapore stock market's relatively late entry into bull territory could bode well for its staying power even as the rally in global equities starts to look a bit stretched.
The Straits Times Index entered a technical bull market Wednesday, climbing more than 20% from its March 23 low. While the benchmark gauge is still down more than 15% this year, bullish option bets and record flows in an exchange-traded fund tracking local stocks show sentiment is improving.
UBS Group AG became the latest fan of the Southeast Asian nation's shares, upgrading its view to overweight in a report Thursday, citing the reopening of global economies, a recovery in oil prices, attractive valuations and the government's ability to contain the damage caused by the coronavirus pandemic.
Singapore stocks are “somewhat cyclical and should benefit from exports and/or oil prices recovering,” said strategists led by Niall MacLeod. The valuations are also “attractive versus the region,” the note added.
Global stocks climbed for eighth straight days through Wednesday on optimism for a quick economic recovery from the virus impact. Technical indicators and valuations are flashing warning signs, however, and the possibility of a second wave of infections poses a threat along with renewed U.S.-China tensions and unrest in U.S. cities.
Singapore's gross domestic product is expected to shrink 4%-7% this year, its worst contraction since independence in 1965, as the pandemic pummels the economy. The Monetary Authority of Singapore has promised to provide sufficient liquidity, while the government has deployed stimulus of S$92.9 billion ($66 billion) so far.
The Singapore government has greater ability than many other nations to support its economy due to its reserves, the UBS strategists wrote in their note. “Therefore non-performing loan risks may be lower than elsewhere.”
While the city-state struggles to flatten the curve of the coronavirus pandemic even as it reopens its economy, UBS said that the number of new cases “is slowing and looks manageable.”
©2020 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.